PFIZER price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- PFIZER
- MB Code
- MBEQU3715
- ISIN
- INE182A01018
- BSE code
- 500680
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 629.23 Cr
- Net profit
- 199.82 Cr
- EPS
- 43.68
- YoY revenue
- +6.31%
Company documents
9 PDFs across 3 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for PFIZER
EPS 41.70 vs est. 40.91
Beat estimates by 1.94%
Pfizer Ltd shares surged over 10% on February 10, 2026, following strong Q3FY26 results with a 20% revenue increase and improved margins …
Pfizer's shares surged 11.2% following the release of its Q3FY26 results, showing an 11% YoY increase in net profit to ₹141.84 crore and …
EPS 40.42 vs est. 36.97
Beat estimates by 9.34%
Pfizer Ltd reported strong Q3 results on February 9, 2026, with a net profit increase of 11.1% YoY to ₹141.8 crore and revenue growth of …
Pfizer shares rose 3.95% following a study published in the New England Journal of Medicine, which revealed that its new mRNA flu vaccine…
Pfizer Ltd. shares surged over 6% following the announcement of a significant increase in Q2 net profit, indicating strong financial perf…
Pfizer has made a significant move into the weight-loss drug sector with a $10 billion acquisition of Metsera, aiming to capture a share …
Price returns
Historical performance
Technicals
Indicator consensus